Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post on X:
“ESMO25 had 4 GU trials in the Presidential plenary sessions!
On behalf of our GU team, we were proud to represent Cleveland Clinic MD for 3/4!
IMvigor011, KN-905, and PSMAddition! Truly grateful to patients and families, my co-investigators, and clinical research team for helping us make meaningful contributions to these practice-changing trials!”
More posts about ESMO25 on OncoDaily.
